JP2013535428A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535428A5
JP2013535428A5 JP2013518819A JP2013518819A JP2013535428A5 JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5 JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5
Authority
JP
Japan
Prior art keywords
rsv
polypeptide
composition
polypeptide epitope
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013518819A
Other languages
English (en)
Japanese (ja)
Other versions
JP5890407B2 (ja
JP2013535428A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/043136 external-priority patent/WO2012006395A1/en
Publication of JP2013535428A publication Critical patent/JP2013535428A/ja
Publication of JP2013535428A5 publication Critical patent/JP2013535428A5/ja
Application granted granted Critical
Publication of JP5890407B2 publication Critical patent/JP5890407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013518819A 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法 Active JP5890407B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36202910P 2010-07-07 2010-07-07
US61/362,029 2010-07-07
US201161485669P 2011-05-13 2011-05-13
US61/485,669 2011-05-13
PCT/US2011/043136 WO2012006395A1 (en) 2010-07-07 2011-07-07 Respiratory syncytial virus antigenic compositions and methods

Publications (3)

Publication Number Publication Date
JP2013535428A JP2013535428A (ja) 2013-09-12
JP2013535428A5 true JP2013535428A5 (https=) 2014-08-07
JP5890407B2 JP5890407B2 (ja) 2016-03-22

Family

ID=45438747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518819A Active JP5890407B2 (ja) 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法

Country Status (13)

Country Link
US (1) US9487593B2 (https=)
EP (1) EP2590675B1 (https=)
JP (1) JP5890407B2 (https=)
CN (2) CN103037898B (https=)
AU (1) AU2011276251B2 (https=)
BR (1) BR112013000345B1 (https=)
CA (1) CA2799934C (https=)
DK (1) DK2590675T3 (https=)
ES (1) ES2688993T3 (https=)
IL (1) IL222723B (https=)
MX (1) MX340796B (https=)
RU (1) RU2609661C2 (https=)
WO (1) WO2012006395A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
MY171498A (en) 2012-08-01 2019-10-15 Bavarian Nordic As Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
IL292567B2 (en) 2013-08-13 2025-06-01 Univ Northwestern Peptide conjugated particles
WO2015183716A1 (en) 2014-05-27 2015-12-03 Artificial Cell Technologies, Inc. Automated layer by layer construction of multilayer coated cores by tff
US9630994B2 (en) 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
WO2017048689A1 (en) 2015-09-16 2017-03-23 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US20170230649A1 (en) * 2016-02-05 2017-08-10 Qualcomm Incorporated Calibration of hybrid auto focus (af) imaging systems
KR102774312B1 (ko) 2017-04-04 2025-03-05 유니버시티 오브 워싱톤 파라믹소바이러스 및/또는 뉴모바이러스 f 단백질을 표시하는 자가-조립 단백질 나노구조체 및 이의 용도
CA3079604A1 (en) 2017-10-13 2019-04-18 Trellis Bioscience, Llc Conformational epitopes in respiratory syncytial virus g protein central conserved region
CA3095216A1 (en) 2018-02-28 2019-09-06 University Of Washington Self-asssembling nanostructure vaccines
EP3833677A4 (en) 2018-08-08 2022-04-27 Trellis Bioscience, Inc. IMPROVED RSV PASSIVE AND ACTIVE VACCINES
US20230414526A1 (en) * 2022-03-29 2023-12-28 Artificial Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2142817C1 (ru) * 1993-08-06 1999-12-20 Коннот Лабораториз Лимитед Инактивированные вакцины респираторно-синцитиального вируса
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
ATE178906T1 (de) 1994-08-25 1999-04-15 Stichting Inst Dierhouderij Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen
FR2726471B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
AUPO026596A0 (en) 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
DE60136381D1 (de) 2000-10-18 2008-12-11 Us Gov Health & Human Serv Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
FR2819810B1 (fr) 2001-01-23 2004-05-28 Pf Medicament Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
AUPR520201A0 (en) 2001-05-23 2001-06-14 Commonwealth Scientific And Industrial Research Organisation Antiviral compounds
JP3997930B2 (ja) 2003-02-27 2007-10-24 富士ゼロックス株式会社 カーボンナノチューブの製造装置および製造方法
US7368537B2 (en) 2003-07-15 2008-05-06 Id Biomedical Corporation Of Quebec Subunit vaccine against respiratory syncytial virus infection
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) * 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
WO2006023029A2 (en) * 2004-06-16 2006-03-02 The Johns Hopkins University The cysteine-rich region of respiratory syncytial virus and methods of use therefor
US20080131450A1 (en) 2004-07-23 2008-06-05 Pierre Fabre Medicament Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions
US20080171070A1 (en) * 2005-01-31 2008-07-17 Pierre Schaaf Polyelectrolyte Multilayer Film, Preparation And Uses Thereof
WO2006108226A1 (en) * 2005-04-12 2006-10-19 The University Of Queensland Vaccine delivery system
CA2627376C (en) * 2005-10-25 2016-07-05 Donald Templeton Haynie Immunogenic compositions and methods of use
EP1972348A1 (en) 2007-03-14 2008-09-24 Pierre Fabre Medicament Novel vaccine composition for the treatment of respiratory infectious diseases
JP2010522540A (ja) 2007-03-21 2010-07-08 アイディー バイオメディカル コーポレイション オブ ケベック キメラ抗原
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
WO2009079066A2 (en) * 2007-09-26 2009-06-25 Aparna Biosciences Therapeutic and vaccine polyelectrolyte nanoparticle compositions
EP2058002A1 (en) * 2007-10-31 2009-05-13 Bestewil Holding B.V. Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine
MX2011000668A (es) 2008-07-18 2011-07-29 Id Biomedical Corp Quebec Antigenos quimericos polipeptidicos del virus sincitial respiratorio.
US20110318376A1 (en) 2008-12-24 2011-12-29 University Of Rochester Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
US8846056B2 (en) 2009-08-04 2014-09-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control Anti-RSV immunogens and methods of immunization
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Similar Documents

Publication Publication Date Title
JP2013535428A5 (https=)
RU2013101972A (ru) Антигенные композиции респираторного синцитиального вируса и способы
JP2015530973A5 (https=)
JP2017529067A5 (https=)
JP2013172734A5 (https=)
JP2017160222A5 (https=)
JP2018532382A5 (https=)
JP2018064568A5 (https=)
JP2009540831A5 (https=)
FI3430027T3 (fi) Peptidi käytettäväksi ei-pienisoluisen keuhkosyövän ja pienisoluisen keuhkosyövän hoidossa
JP2004115529A5 (https=)
JP2016512213A5 (https=)
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
CN103417480A (zh) 一种靶向整合素受体的新型多肽修饰的肿瘤靶向脂质体
JP2013127002A5 (https=)
JP2016196472A5 (https=)
JP2015509085A5 (https=)
JP2019516663A5 (https=)
JP2016533174A5 (https=)
JP2013502918A5 (https=)
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
JP2019530441A5 (https=)
HK1200842A1 (en) Proteins with improved half-life and other properties
WO2012009524A3 (en) Magnetic storage element comprising a functional layer in the pinned layers and manufacturing method thereof
JP2013518057A5 (https=)